Heska

Heska, established in 1988, is a prominent entity in the Pharmaceuticals and Healthcare sectors, dedicated to the discovery, development, manufacturing, and marketing of advanced companion animal health products. Primarily serving dogs, cats, and horses, the company also extends its expertise to diagnostic and patient monitoring equipment, alongside diagnostic laboratory products. With a significant operational footprint, Heska serves markets across the United States and Europe, underscoring its global reach in veterinary medicine. Its commitment to innovation drives the creation of specialized solutions aimed at improving animal well-being and diagnostic accuracy within the veterinary field.

Operating with a dedicated workforce of 500 - 1,000 employees, Heska manages a network of 14 locations, facilitating its comprehensive product distribution and service delivery. The company's product portfolio encompasses a wide array of veterinary diagnostics, including hematology, chemistry, and allergy testing solutions, alongside imaging equipment like digital radiography and ultrasound. This robust offering supports veterinary professionals in delivering precise diagnoses and effective treatments for companion animals. For insights into the people driving these advancements, explore Meet Heska's team.

Heska competes in a dynamic market against key players such as Abaxis and Vetoquinol USA, among others. The company reported a substantial revenue of $257.3M, reflecting its strong market presence and product demand. Its strategic focus on specialized veterinary diagnostics and therapeutics positions it as a key contributor to animal health innovation. Further details on its financial performance and market standing are available via Explore financial highlights.